Microbix Biosystems Inc.

TSX:MBX Stock Report

Market Cap: CA$67.8m

Microbix Biosystems Future Growth

Future criteria checks 2/6

Microbix Biosystems is forecast to grow revenue at 20.8% per annum. EPS is expected to grow by 39.3% per annum.

Key information

n/a

Earnings growth rate

39.3%

EPS growth rate

Biotechs earnings growth-3.3%
Revenue growth rate20.8%
Future return on equityn/a
Analyst coverage

Low

Last updated20 Dec 2024

Recent future growth updates

Microbix Biosystems Inc. (TSE:MBX) Just Reported Earnings, And Analysts Cut Their Target Price

Feb 17
Microbix Biosystems Inc. (TSE:MBX) Just Reported Earnings, And Analysts Cut Their Target Price

Recent updates

Microbix Biosystems Inc. (TSE:MBX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Jan 04
Microbix Biosystems Inc. (TSE:MBX) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Microbix Biosystems' (TSE:MBX) Shareholders Should Assess Earnings With Caution

Aug 22
Microbix Biosystems' (TSE:MBX) Shareholders Should Assess Earnings With Caution

Why Microbix Biosystems' (TSE:MBX) Earnings Are Weaker Than They Seem

Feb 21
Why Microbix Biosystems' (TSE:MBX) Earnings Are Weaker Than They Seem

Microbix Biosystems Inc. (TSE:MBX) Just Reported Earnings, And Analysts Cut Their Target Price

Feb 17
Microbix Biosystems Inc. (TSE:MBX) Just Reported Earnings, And Analysts Cut Their Target Price

Microbix Biosystems Inc.'s (TSE:MBX) Shares Climb 29% But Its Business Is Yet to Catch Up

Dec 23
Microbix Biosystems Inc.'s (TSE:MBX) Shares Climb 29% But Its Business Is Yet to Catch Up

Is Microbix Biosystems (TSE:MBX) Using Debt Sensibly?

Nov 03
Is Microbix Biosystems (TSE:MBX) Using Debt Sensibly?

Is Microbix Biosystems (TSE:MBX) Using Debt In A Risky Way?

Jul 22
Is Microbix Biosystems (TSE:MBX) Using Debt In A Risky Way?

Some Shareholders Feeling Restless Over Microbix Biosystems Inc.'s (TSE:MBX) P/S Ratio

May 17
Some Shareholders Feeling Restless Over Microbix Biosystems Inc.'s (TSE:MBX) P/S Ratio

Time To Worry? Analysts Are Downgrading Their Microbix Biosystems Inc. (TSE:MBX) Outlook

Dec 27
Time To Worry? Analysts Are Downgrading Their Microbix Biosystems Inc. (TSE:MBX) Outlook

Microbix Biosystems (TSE:MBX) Has A Pretty Healthy Balance Sheet

Aug 08
Microbix Biosystems (TSE:MBX) Has A Pretty Healthy Balance Sheet

Microbix Biosystems' (TSE:MBX) Solid Profits Have Weak Fundamentals

May 20
Microbix Biosystems' (TSE:MBX) Solid Profits Have Weak Fundamentals

Microbix Biosystems (TSE:MBX) Seems To Use Debt Quite Sensibly

Feb 06
Microbix Biosystems (TSE:MBX) Seems To Use Debt Quite Sensibly

One Microbix Biosystems Inc. (TSE:MBX) Analyst Just Made A Major Cut To Next Year's Estimates

Dec 28
One Microbix Biosystems Inc. (TSE:MBX) Analyst Just Made A Major Cut To Next Year's Estimates

Is Microbix Biosystems (TSE:MBX) A Risky Investment?

Oct 14
Is Microbix Biosystems (TSE:MBX) A Risky Investment?

Microbix Biosystems Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Aug 15
Microbix Biosystems Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

A Look At The Fair Value Of Microbix Biosystems Inc. (TSE:MBX)

May 17
A Look At The Fair Value Of Microbix Biosystems Inc. (TSE:MBX)

Most Shareholders Will Probably Find That The CEO Compensation For Microbix Biosystems Inc. (TSE:MBX) Is Reasonable

Mar 24
Most Shareholders Will Probably Find That The CEO Compensation For Microbix Biosystems Inc. (TSE:MBX) Is Reasonable

Earnings and Revenue Growth Forecasts

TSX:MBX - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202746N/AN/AN/A1
9/30/202637N/AN/AN/A1
9/30/202528N/AN/AN/A1
9/30/202425424N/A
6/30/202423502N/A
3/31/202424423N/A
12/31/202322401N/A
9/30/2023170-2-1N/A
6/30/202317-3-21N/A
3/31/202316-1-11N/A
12/31/202217013N/A
9/30/202219213N/A
6/30/202220345N/A
3/31/202221412N/A
12/31/202120412N/A
9/30/202119312N/A
6/30/202116-3-10N/A
3/31/202113-402N/A
12/31/202012-6-10N/A
9/30/202011-6-10N/A
6/30/202011-101N/A
3/31/202012-1-10N/A
12/31/201913000N/A
9/30/201913000N/A
6/30/201913-800N/A
3/31/201913-800N/A
12/31/201812-901N/A
9/30/201813-9-2-1N/A
6/30/201812-1N/A-1N/A
3/31/201811-1N/A-1N/A
12/31/201711-1N/A-1N/A
9/30/201710-4N/A0N/A
6/30/201711-2N/A1N/A
3/31/201710-2N/A1N/A
12/31/201610-2N/A1N/A
9/30/2016101N/A1N/A
6/30/201680N/A1N/A
3/31/201680N/A0N/A
12/31/201580N/A0N/A
9/30/201591N/A1N/A
6/30/201590N/A0N/A
3/31/201590N/A0N/A
12/31/201480N/A-1N/A
9/30/201480N/A-1N/A
6/30/201491N/A1N/A
3/31/201481N/A1N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if MBX's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if MBX's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if MBX's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: MBX's revenue (20.8% per year) is forecast to grow faster than the Canadian market (4.9% per year).

High Growth Revenue: MBX's revenue (20.8% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if MBX's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 16:38
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Microbix Biosystems Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David MartinBloom Burton & Co.
Neil LinsdelliA Capital Markets